{"id":"n_tej25grrdyf5dpcbxgza","seq":11393450,"kind":"article","title":"F.D.A. Rejects Closely Watched Lung Cancer Drug From China","url":"https://www.nytimes.com/2026/11/15/business/fda-lung-cancer-drug-china.html","summary":"The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.","published":"2026-11-15T20:33:07Z","seen":"2026-11-15T20:47:01Z","lang":"en","country":"US","source":{"id":"kite-nytimes-com-8dc54e","name":"nytimes.com","domain":"nytimes.com"},"via":"kite-nytimes-com-8dc54e","topics":["asia","drugs (pharmaceuticals)","international relations","regulation and deregulation of industry","cancer","lung cancer","biotechnology and bioengineering","clinical trials"],"authors":["Rebecca Robbins"],"mentions":4,"story":"st_tej25grrdyf5dpcbxgza","category":"health","category_p":0.38,"category2":"politics","sentiment":"negative","tone":-0.51,"political":0.85}